Document ID: chunk:federal_register_of_legislation:C2015C00461:section:10:p2
Version: federal_register_of_legislation:C2015C00461
Segment Type: section
Provision Reference: s 10 (pt 2/24)
Character Range: 14566–17470

made on prescription in pharmacies.
       (j) "Illicit traffic" means manufacture of or trafficking in psychotropic substances contrary to the provisions of this Convention.
       (k) "Region" means any part of a State which pursuant to article 28 is treated as a separate entity for the purposes of this Convention.
       (l) "Premises" means buildings or parts of buildings, including the appertaining land.

ARTICLE 2
Scope of control of substances
1. If a Party or the World Health Organization has information relating to a substance not yet under international control which in its opinion may require the addition of that substance to any of the Schedules of this Convention, it shall notify the Secretary‑General and furnish him with the information in support of that notification. The foregoing procedure shall also apply when a Party or the World Health Organization has information justifying the transfer of a substance from one Schedule to another among those Schedules, or the deletion of a substance from the Schedules.
2. The Secretary‑General shall transmit such notification, and any information which he considers relevant, to the Parties, to the Commission and, when the notification is made by a Party, to the World Health Organization.
3. If the information transmitted with such a notification indicates that the substance is suitable for inclusion in Schedule I or Schedule II pursuant to paragraph 4, the Parties shall examine, in the light of all information available to them, the possibility of the provisional application to the substance of all measures of control applicable to substances in Schedule I or Schedule II, as appropriate.
4. If the World Health Organization finds:
       (a) that the substance has the capacity to produce
              (i) (1) a state of dependence, and
              (2) central nervous system stimulation or depression, resulting in halucinations or disturbances in motor function or thinking or behaviour or perception or mood, or
            (ii) similar abuse and similar ill effects as a substance in Schedule I, II, III or IV, and
 (b) that there is sufficient evidence that the substance is being or is likely to be abused so as to constitute a public health and social problem warranting the placing of the substance under international control,
the World Health Organization shall communicate to the Commission an assessment of the substance, including the extent or likelihood of abuse, the degree of seriousness of the public health and social problem and the degree of usefulness of the substance in medical therapy, together with recommendations on control measures, if any, that would be appropriate in the light of its assessment.
5. The Commission, taking into account the communication from the World Health Organization, whose assessments shall be determinative as to medical and scientific matters, and bearing in mind